Impact of Blood Pressure on Allograft Function and Survival in Kidney Transplant Recipients.

Abstract

The optimal target blood pressure for kidney transplant (KT) patients remains unclear. We included 808KT patients from the KNOW-KT as a discovery set, and 1,294KT patients from the KOTRY as a validation set. The main exposures were baseline systolic blood pressure (SBP) at 1year after KT and time-varying SBP. Patients were classified into five groups: SBP <110; 110-119; 120-129; 130-139; and ≥140mmHg. SBP trajectories were classified into decreasing, stable, and increasing groups. Primary outcome was composite kidney outcome of ≥50% decrease in eGFR or death-censored graft loss. Compared with the 110-119mmHg group, both the lowest (adjusted hazard ratio [aHR], 2.43) and the highest SBP (aHR, 2.25) were associated with a higher risk of composite kidney outcome. In time-varying model, also the lowest (aHR, 3.02) and the highest SBP (aHR, 3.60) were associated with a higher risk. In the trajectory model, an increasing SBP trajectory was associated with a higher risk than a stable SBP trajectory (aHR, 2.26). This associations were consistent in the validation set. In conclusion, SBP ≥140mmHg and an increasing SBP trajectory were associated with a higher risk of allograft dysfunction and failure in KT patients.